Proton-pump inhibitors (PPI) have long been considered as the ideal treatment for gastroesophageal reflux disease (GERD), and their limitations and side effects have revealed a need for new therapeutic approaches. At present, the therapeutic gains achieved are relatively small or limited to groups of patients with specific characteristics. This article updates the contributions, indications, and limitations of pharmacological, endoscopic, and surgical treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17235/reed.2020.7648/2020 | DOI Listing |
Publication Analysis
Top Keywords
reflux disease
8
gastro-esophageal reflux
4
disease limits
4
limits medical
4
medical treatment
4
treatment surgical
4
surgical indications
4
indications proton-pump
4
proton-pump inhibitors
4
inhibitors ppi
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!